IDX vs PCK

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IDX

INTEG DIAG FPO [IDX]

47LOW

PCK

PAINCHEK FPO [PCK]

47LOW

Score Breakdown

IDX PCK
Technical
63
47
Catalyst
50
52
Sentiment
50
50
Fundamental
91
56
Momentum
72
30
Risk Gate
34
42

Key Metrics

IDX Metric PCK
$872.6MMarket Cap$29.3M
1.1MAvg Volume (20d)116K
+2.8%Short InterestN/A
$3.07052-Week High$0.355
$2.11052-Week Low$0.140
+0.4%Daily Change+0.0%
$2.370Entry Price$0.140
+2.1%ROE-383.2%
+1.8%Profit Margin-268.1%

Active Signals

IDX Signals

Volume surging at 2.0x normal while price climbs — real buying conviction behind this move
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (1.1x)
Strong revenue growth (+56%)
EPS estimates revised upward (+10pts)

PCK Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Took a hit — down 15.2% over the last 5 days
Volatility is contracting — like a spring being compressed, breakouts often follow
Low cash runway (3 quarters) - dilution risk
Moderate P/S ratio (8.5x)

Ask Scout AI to compare IDX and PCK in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IDX Full Analysis → PCK Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).